{"id":22436,"date":"2019-01-07T14:57:56","date_gmt":"2019-01-07T14:57:56","guid":{"rendered":"http:\/\/www.neurodegenerationresearch.eu\/?p=22436"},"modified":"2019-04-10T14:28:18","modified_gmt":"2019-04-10T14:28:18","slug":"jpnd-launches-e30-million-call-for-multinational-research-on-personalised-medicine-for-neurodegenerative-diseases","status":"publish","type":"post","link":"https:\/\/neurodegenerationresearch.eu\/sl\/2019\/01\/jpnd-launches-e30-million-call-for-multinational-research-on-personalised-medicine-for-neurodegenerative-diseases\/","title":{"rendered":"JPND launches \u20ac30 million call for multinational research on personalised medicine for neurodegenerative diseases."},"content":{"rendered":"

The EU Joint Programme \u2013 <\/em>Neurodegenerative Disease Research (JPND) initiative <\/em>has announced a joint transnational call for multinational research on personalised medicine for neurodegenerative diseases.<\/p>\n

Neurodegenerative diseases are debilitating and still largely untreatable conditions. These diseases are characterised by a large variability in their origins, mechanisms and clinical expression, requiring treatments that will need to take into account all these specificities. Deciphering this variability is one of the biggest challenges in the treatment of neurodegenerative diseases and the way forward is Precision Medicine<\/strong>, supported by highly personalised approaches for the greatest benefit of the patients.<\/p>\n

In this context, in partnership with the European Commission, JPND announced today a new call, inviting multinational research teams to submit proposals for ambitious, innovative, multinational and multidisciplinary collaborative research projects to change the trajectory of these debilitating diseases through the development of Precision Medicine approaches.<\/strong><\/p>\n

JPND has chosen to focus in the area of Precision Medicine, which relates to the targeting of specific elements responsible for pathology in a given individual at a particular point in time. It is an emerging approach for disease prevention, diagnosis and treatment that takes into account individual variability in genes, biological\/molecular characteristics together with environmental and lifestyle factors.<\/p>\n

According to Professor Philippe Amouyel, University of Lille (France) and Chair of the JPND <\/strong>Management Board:<\/strong><\/p>\n

\"\"

Professor Philippe Amouyel, Chair of JPND<\/p><\/div>\n

\u201cDuring the last ten years, researchers have progressively uncovered the high complexity and wide diversity of neurodegenerative diseases. We need now to complete and use this massive amount of knowledge to develop targeted approaches to more efficiently fight the dramatic progression of these diseases.\u201d<\/em><\/p>\n

According to Professor Thomas Gasser, University of T\u00fcbingen (Germany) and Chair of the JPND Scientific Advisory Board:<\/strong><\/p>\n

\u201c<\/em>Progresses in precision medicine will be a unique way to develop innovative approaches to prevent, slow down\u00a0and cure neurodegenerative diseases. This call aims to harness the necessary expertise across Europe and globally, to address this research challenge.<\/em> \u201d <\/em><\/p>\n

Professor Amouyel added: \u201cWith this in mind, JPND participating countries in close collaboration with the European Commission have identified precision medicine as a major issue to tackle the global challenge of neurodegenerative diseases.\u201d<\/em><\/p>\n

Proposals submitted under this call, which is open to applicants in 24 countries<\/a>, must focus on Precision Medicine in one or several of the following research areas:<\/p>\n